Michael Wang

45.3k citations
573 papers · 17.6k · 6 hit papers · h-index 65

Impact in

  • Hematology top 0.1%
    • Multiple Myeloma Research and Treatments
  • Oncology top 0.1%
    • CAR-T cell therapy research
    • Viral-associated cancers and disorders
    • Peptidase Inhibition and Analysis

Papers in

Michael Wang

530 papers receiving 17.3k citations

Michael Wang's Hit Papers

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials 2019 · 628 citations
6280+6+12Years since publication250500750

Peers

Michael Wang
Comparison fields: 5 of 163
  • Hematology 4.0k
  • Oncology 7.9k
  • Genetics 2.9k
  • Pathology and Forensic Medicine 4.6k
  • Immunology 2.6k
Replace Andrew W. Roberts with:
Andrew W. Roberts Australia
Robin Foà Italy
Govind Bhagat United States
Edo Vellenga Netherlands
Dario Campana United States
Maher Albitar United States
John G. Gribben United Kingdom
Steven T. Rosen United States
Dieter Hoelzer Germany
Franco Dammacco Italy
Michael Wang relative to Andrew W. Roberts Australia Andrew W. Roberts's profile →
Citations per field
00.5×1.7×
Andrew W. Roberts · 1×
Citations per year

Countries citing papers authored by Michael Wang

Since Specialization
Citations

This map shows the geographic impact of Michael Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wang more than expected).

Fields of papers citing papers by Michael Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wang. The network helps show where Michael Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Wang Line = papers co-authored together Michael Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 573 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Hit paper breakdown →
2007955
2
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Hit paper breakdown →
2019628
3
T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
Hit paper breakdown →
2016619
4
Seroepidemiology of Human Polyomaviruses
Hit paper breakdown →
2009602
5
T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
Hit paper breakdown →
2018580
6
Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol
Hit paper breakdown →
2009538
7 2004436
8 2005400
9 2008379
10 1999352
11 1998267
12 2009253
13 2007195
14 2014194
15 2008189
16 2016186
17 2010185
18 2010175
19 2014174
20 2020165

About Michael Wang

Michael Wang is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology and Hematology, having authored 573 papers that have together received 17.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (288 papers), Chronic Lymphocytic Leukemia Research (195 papers), Multiple Myeloma Research and Treatments (105 papers), CAR-T cell therapy research (104 papers), Viral-associated cancers and disorders (60 papers), Protein Degradation and Inhibitors (52 papers), Ubiquitin and proteasome pathways (33 papers) and Cancer Treatment and Pharmacology (26 papers). The work is most often cited by research in Hematology (4.0k citations), Oncology (7.9k citations), Genetics (2.9k citations), Pathology and Forensic Medicine (4.6k citations) and Immunology (2.6k citations). Michael Wang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Michael S. Brown, Joseph L. Goldstein, Rodney E. Infante, Preetesh Jain, Hyock Joo Kwon, Jorge Romaguera, Robert L. Garcea, Suchitra Rao, Larry W. Kwak and Luis Fayad. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Journal of Hematology & Oncology and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact